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NetworksAparagraph from thehighlights of “Transcriptomics: Throwing light on darkmatter”by L. Flintoft (Nature ReviewsGe-
netics 11, 455, 2010), says: “Reports over the past few years of extensive transcription throughout eukaryotic ge-
nomes have led to considerable excitement. However, doubts have been raised about the methods that have
detected this pervasive transcription and about how much of it is functional.” Since the appearance of the
ENCODE project and due to follow-up work, a shift from the pervasive transcription observed from RNA-Seq data
to its functional validation is gradually occurring. However, much less attention has been turned to the problem
of deciphering the complexity of transcriptome data, which determines uncertainty with regard to identiﬁcation,
quantiﬁcation and differential expression of genes and non-coding RNAs. The aim of this mini-review is to empha-
size transcriptome-related problems of direct and inverse nature for which novel inference approaches are needed.
© 2014 Capobianco. Published by Elsevier B.V. on behalf of the Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY license
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Next Generation Sequencing (NGS) and Big Data are companions in
the fascinating life science era. The great impacts in biomedicine
which are expected from their clever exploitation are stimulating excit-
ing research at all latitudes. Given the fact that a growing number andi, Miami, FL, USA.
.V. on behalf of the Research Netwo
s/by/4.0/).variety of data-intensive NGS applications are also expected, and that
technologies are constantly subject to reﬁnements, the estimation of
data-robust information bounds establishing a reference or benchmark
for the quality, reliability and signiﬁcance of the results is destined to re-
main a purely theoretical task. In the meantime, debating the current
knowledge gaps can be also useful, and central to our review is the
observation that the entire RNA cellular component is comprised by
the transcriptome [1], implying that the estimation of the expressed
transcripts will determine the regulation networks underlying key
phenotypes, in particular in relation with disease.rk of Computational and Structural Biotechnology. This is an open access article under
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require the assimilation of large volumes of data into computational
pipelines designed for speciﬁc inference tasks, i.e., identiﬁcation, quan-
tiﬁcation, differential expression, proﬁling, annotation, prediction etc.
However, when looking at the targets of such tasks, even for the tran-
scripts assumed to be known, e.g. the protein coding genes, there is
not yet clear consensus about what could be deﬁned a representative
number of them. The knowledge gap further extends when structural
complexity (small-large non-coding RNAs, novel transcripts from non-
annotated genes, splicing isoforms etc.) comes into the picture, and re-
dundancy and noise need to be considered.
Several complexities arise from transcriptome measurements, and
these transfer over the data. RNA-Seq [2–4] deliver transcriptome snap-
shots by estimating the copy number of the transcripts in samples, and
the results allow for accurate digital gene expression measurements
and prediction of novel transcripts. Two main problems are worth
mentioning:
1. Read mapping uncertainty [5]. In general, reconstructing full-length
transcripts requires an assembly phase, except for the small RNAs
that are often shorter than the already short sequence reads obtained
from the common platforms. Therefore, ambiguity occurs because of
a limited resolution, and from the fact that transcript variants origi-
nated from the same gene may share exons.
2. Coverage [6], which varies across transcripts as a consequence of the
fact that transcripts are expressed at different levels and have differ-
ent lengths (among other factors producing biases, like GC content,
for instance). Therefore, transcripts that are consistent with knownFig. 1. Concepts describing complexityisoforms may remain incompletely assessed due to limited coverage,
and lowly or broadly expressed genes are less supported by RNA-Seq
compared to abundant transcripts, which are instead fully assembled.
Other known problems are sequencing non-uniformity, estimation
of novel isoforms (alternatively spliced transcripts), and quantiﬁcation
of expression levels. While it appears likely that novel complexities
will emerge from data structures generated by newly designed experi-
ments, it is important to consider the data available in public reposito-
ries, as they are becoming natural target of scientiﬁc reuse. This data
multitude requires integration strategies to deal with heterogeneous
sources and categorized entities, thus suggesting the need of identifying
speciﬁc features in variables and parameters which should shape the
spectrum of inference tools.
A few questions can be formulated with regard to establishing a
rationale behind the choice of an inference approach for RNA-Seq
data: a) Given a certain problem complexity, what is the best possible
approach in terms of reproducibility of solutions? b) What conditions
should lead to model-based versus model-free (data-driven) methods?
c) How to ensure that statistical estimates are reasonably accurate?
It is generally known that solving an inverse problem entails deter-
mining unknown causes based on the observation of their effects, unlike
for a direct problem in which the solution involves ﬁnding effects based
on a complete description of their causes. One of the least noticed aspect
in ‘omics’ applications is thatmanyproblems have an inverse nature [7].
For these, ad hoc statistical inference may solve the convolutions
between complex multi-parameter variables, and new strategies may
involve the multilevel power of networks, as explained below., and corresponding architecture.
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Fig. 1 provides the reference for the proposed analysis on complexity
underlying RNA-Seq data, and suggests a series of problems, each
speciﬁed in detail. The informative layers are three:
i) Top layer: Big Data structures;
ii) Middle layer: a Cartesian coordinate system with a view of
translational topics; and
iii) Bottom layer: target bio-applications.
In particular, a system's viewwould embed these three components
and establish for the top layer the function of data generation, for the
middle layer the role of themethodological core whose complex design
is dissected into quadrants linked to tasks, actions and applications, and
for the bottom layer the systems outcome.
Problem #1. Sequencing depth. Regulation of such factor at the ex-
perimental level is known to inﬂuence the depth of discovery achiev-
able from the data, thus determining the impact of computational
methods.
The ﬁrst quadrant includes terms like inverse problem and
deconvolution (see also Box 1), which provide methods for model
identiﬁcation, estimation and testing. Assessment of uncertainty
for the measured values is also reported. In particular, re-sampling
deals with testing data structures for the presence of real and signif-
icant features. Statistical techniques offer many solutions. OneBox 1
Dimensional model reduction
Methods such as compressed sensing/sampling (CS), principal/
independent/sparse component analysis, latent factor analysis
represent well-known dimensionality reduction techniques
adopted in statistical inference andmachine learning. CSmodeling
simplifies the ‘reduction’ task compared to other probabilistic
alternatives which are usually based on maximum likelihood
estimation, bringing thus the risk of inconsistent results in
dependence on the nature of the data.
Model mis-specification is a possibility whenever distributional
assumptions (say, Gaussianity) do not hold, and in such cases
different likelihood functions can be associated with the data
(e.g. pseudo-likelihood, profile likelihood, and penalized likelihood)
thus switching from model-based to data-driven approaches.
However, some problems are naturally ‘inverse’, and call for regu-
larized solutions to correct for their ‘ill-posedness’, e.g. their solu-
tion is unstable under data perturbation. Numerical methods thus
can cope with such limitations, and CS optimization is suitable
for such task.
Deconvolution
Signal deconvolutionmethods represent a possible strategy to ad-
dress inverse problems, and are employed to recover an accept-
able signal-to-noise ratio in situations in which this is too low
due to convolution of signal with response and other systems
interferences. Thesemethods call for projective approaches in sta-
tistical applications, usually relying on non-parametric inference
solutions, and also involve a sequence of algorithmic steps such
as filtering, smoothing and prediction when signal processing
problems are under investigation.strategy involves building null models as a benchmark for the valida-
tion of results. Sampling and re-sampling (SRS) techniques point to
well-known solutions such as jackknife, bootstrap, permutations
and cross-validation. In some cases, when the parametric assump-
tions are in doubt, the risk of mis-speciﬁcation is high, and systemat-
ic analytical efforts are required to compute standard errors of the
estimates.
Problem #2. Transcript structures include protein-coding genes and
non-coding RNA biotypes that need to be cross-examined to annotate
as many entities as possible that connect genotype to phenotype of a
cell. The examination of transcripts arising from intergenic regions
(i.e. lincRNA) should help to elucidate functional relevance by generat-
ing testable hypothesis subject to further validations.
The second quadrant includes complexities. Among their determi-
nants, data dimensionality (low-high) and scale (poor–rich), together
with variables' heterogeneitywith both functional relationships (linear–
nonlinear) and parameter settings (ﬁnite–inﬁnite), are among the most
important entities. The transcriptome characterization involves both
the discovery of biotypes, and an assembly phase with accurate and
quantitative mapping of billions of reads to small/large reference ge-
nomes, aiming at the simultaneous reconstruction of all full-length
mRNA transcripts from the available short/long reads.
Problem #3. The multidimensionality of transcriptome proﬁling is a
key factor. While estimating dynamically the expression proﬁles, map-
ping them to gene and protein networks can help driving inference on
yet unexplored RNA functional regulation of the transcriptome.
The third quadrant addresses dimensions that are relevant for expres-
sion proﬁling; these are time and space. Data structures embedding both
dimensions require particular experimental designs, which are rarely
accessible from public resources. Treating data in the presence of both
dimensions requires an adaptation of current computational algo-
rithms: see for instance the proposals of [8,9] in which complex biolog-
ical variability makes both statistical multifactoriality and robustness
central to the analysis. In large part, innovative solutions are currently
unavailable to address a dynamic enhancement of expression proﬁles to-
ward spatiotemporal extensions. Among the possible reasons, one re-
fers to the data structure, especially with reference to time course
proﬁles embedding dependencies that cannot be treated based on
data replication strategies or assuming independence that are of com-
mon use in simple condition-speciﬁc dynamics.
Problem #4. Evidence of identiﬁed isoforms represents a knowledge
basis on variation. Model reduction techniques need to be applied to
the isoform space to allow recovery and prediction.
The fourth quadrant includes alternative splicing (AS), and addresses
the related problem of measuring and modeling isoforms. AS (see [10],
and the inserted references n. 1–15 for functional role and references n.
16–25 for involvement in disease, and [11] for variability in humanpop-
ulations) is a commonmechanism of gene regulation in higher eukary-
otes, which occurs in over 90% of multi-exon genes in the human
genome and is regulated by complex interactions between cis-acting
splicing elements and trans-acting factors. Many splicing regulators
have tissue-speciﬁc expression patterns, resulting in widespread differ-
ences in AS patterns across different tissues. In connection with
Problem #3, the consideration of AS spatiotemporal dynamics may
help isoform identiﬁcation and recovery problems [12–16]. In general,
depending on the assumptions about the isoforms, a model reduction
strategy is considered relevant, i.e. a subset of measurable isoforms
spanning or approximating the included isoforms (also the unknown
ones). In most cases the isoform space is a hidden information layer
destined to remain ignored, and thus what is empirically found from
the sequence processing is redundancy difﬁcult to handle or even
interpret.
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promising ones:
a. Analyze human transcriptome complexities by characterizing multidi-
mensional expression proﬁles, pathway landscapes and wide-
spectrum transcript structures.
b. Provide better transcript annotations, possibly extending them with
new ones;
c. Select inference approaches for inverse problems targeted to both iso-
form deconvolution (transcript quantiﬁcation) and isoform prediction;
d. Elucidate role and function of isoforms to provide further insights into
the unknown transcriptome functionalization.3. Multiscale view
Transcriptome-related complexities are difﬁcult to decipher, analyze
and predict due to their co-dependence over at least three scales: data,
methods and applications. Statistical complexity [17] refers to the pres-
ence of non-trivial hidden patterns in the system's dynamics, reﬂecting
an information-disequilibrium interplay. Consequently, we should ﬁrst
account for statistical ﬂuctuations in a system observed through ﬁnite
samples and then, from the interdependence between complexity and
distance, address the relationships between dynamic patterns and ﬂuc-
tuations, as the system's outcomesmayoccurwith empirical (observed)
frequencies (probabilities) which can be different from the expected
(theoretical) ones.
In general, given an experimental data generation process, any rep-
licated data should aim to produce measurements with controlled var-
iation, i.e. bounded by the average ﬂuctuation. However, the assessment
of such variation bounds to discriminate between transcriptional enti-
ties and noise remains highly uncertain. Usually, algorithmic and data
intensive RNA-Seqpipelines of both probabilistic and heuristic speciﬁca-
tions are employed agnostically, following two main directions:
1) Customization of model solutions to experimentally generated data
(narrowing down the problem). Results which are difﬁcult to generalize
involve the analysis of degree of overﬁtting possibly present in the
data. Examples of this form of bias are provided by typical parametric
models, which are based on model-specifying assumptions.
2) Adaptation to data features (relaxing the problem from constraints).
Often, the complexity cannot be properly handled, because the problem
is not sufﬁciently regularized. Examples are provided by solutions aris-
ing from non-parametric models, which are simply data-driven.
The consideration of the multiscale nature of expression proﬁling is
often overlooked. Regarding time-related dependencies, a recent ad-
vance is worth mentioning [18]. Spatiotemporal dynamics are not di-
rectly covered in RNA-Seq pipelines, rising doubts about how to
algorithmically handlewith numerical precision and statistical accuracy
the time-course information and/or the spatial heterogeneity in many
data-intensive applications. However, systems-level research targeted
to complex biological systems and their pathological alterations is de-
pending on spatiotemporal analysis.
For instance, recent advances in single cell technologies are contrib-
uting to novel transformative approaches and challenges in computa-
tional biology (two recent examples are [19,20]). This is due to the
new possibilities of improving the task of monitoring biological systems
atmultiple temporal, spatial andmolecular resolutions at the single cell
level. Single cell proﬁling approaches allow the screening of transcript
amounts referred to many different markers, enabling the evaluation
of whole transcriptomes and genomes for single cells. Consequently, in-
formation about complex phenotypes investigated in heterogeneous
cell populations will be possible; an example is cancer and its well-
known altered hierarchy of cell sub-populations for which future per-
spectives are to ﬁndnovel therapeutic targets, to discover new function-
ally relevant cell types, and to infer cell-to-cell variability phenomena in
a variety of cell populations.Problems involving the detection of unknown isoforms and the esti-
mation of their expression values, usually refer to a given isoform space.
Finding a solution path in complex high-dimensional data spaces re-
quires model reduction approaches to handle the dimensionality (see
Box 1). In the context of isoform modeling, solutions may be adapted
to a rich class of analysis methods involving projections in new coordi-
nate spaces fromwhich to assess the systems dependencies. In particu-
lar, the domain of compressed sensing/sampling (CS) techniques [21,22]
is yet to be explored, togetherwith othermethods dealingwith principal
and independent components, or with sparse or latent factors.
The rationale for such applications is offered by the advantage of
exploiting the inherent partial knowledge of the isoform vector at-
tached to each gene, i.e. the fact that M of the N given values, with
M b N, are quantiﬁed and the rest are not (the unknown part of the vec-
tor). The commonpractice of considering a parsimonious set of isoforms
based on the expression values is not exempt from risks, due to the fact
that other informative isoform features (in relation to structure, locali-
zation, etc.) would be excluded by a selection criterion based just on ex-
pression values. Such features could then be included in the sensing
matrix for determining the measurements of the isoforms. CS modeling
would simplify the reduction problem compared to probabilistic alter-
natives based on maximum likelihood types of estimation, which may
result inconsistent with the nature of the data.
However, the inverse nature of the problem suggests that regular-
ized solutions might be needed. This aspect can be explored within a
CS optimization context. In particular, an isoform stochastic context ad-
dresses equivalently a signal recovery problem in which the observed
variables are modeled through latent or hidden components. When
the latter exist, they need to be unambiguously identiﬁed and estimat-
ed. The other way to look at this class of problems is to consider data de-
compositions, and in our case the RNA-Seq landscape would be the
candidate for such decomposition aimed at extracting underlying signa-
tures. Assessing the impact of AS on the expression proﬁles could be a
goal for a detection algorithm, but other signatures could be targeted
too, including transcriptional noise whose role remains ambiguously
present when studying non-coding RNA structure characterizations.4. Transcriptome landscape analysis and structure recovery
The complex layers emerging from analyses at transcript scale are
substantially convoluted, preventing from a clear identiﬁcation of sepa-
rate effects. The overall complexity translates in part into pervasive
transcription, functionalization, and integrative regulation. For instance,
pervasive transcription [23,24] involves complexity factors such as:
i) Regions characterized by long ncRNA [25], with speciﬁc interactions
and functions; ii) LincRNA [26–30], and for applications see [31–33]
which are currently not covered by annotation; iii) Transcriptional
noise; and iv) Fragments of known pre-mRNA. A full elucidation of
such aspects is not trivial.
One problem is that lowly/broadly expressed transcripts areweakly/
incompletely supported by RNA-Seq; while the abundant transcripts are
represented bymany reads, the rare transcripts are represented by only
a few reads. For instance, while in general lincRNAs show less abun-
dance than protein-coding genes, are less expressed and have a tissue/
cell-speciﬁc expression pattern, these RNAs are multi-exon transcripts
mapping to intergenic regions, in which most of transcribed mRNAs
do not encode proteins.
Overall, many RNA-Seq experiments have shown read density more
than 100-fold higher in exons than in introns or intergenic regions. De-
spite the biological role ofmost of the intergenic transcripts still remains
poorly understood or unknown, many of them possess functional roles.
Indeed, the genomic loci of many lincRNA lie close to neighborhood
genes, presenting smaller size and shorter transcripts. Thus, it has
been proposed a regulatory role of these transcripts on proximal
genes, and a potential role on AS of mRNA isoforms.
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forms, in agreement with the current knowledge that about 90% of
genes generate alternative mRNA isoforms. mRNA complexity refers
to the extent bywhich alternative RNA isoforms contribute to functional
diversity. It is known that a small number of RNA regulatory proteins
may produce a vast diversity of biological outcomes. These consider-
ations are conﬁrmed by studies such as ENCODE, showing that known
isoforms account for about 80% of RNA-Seq fragments due to highly
expressed genes that are involved,while a residual 11% of the fragments
map to novel isoforms of known genes.
5. What's next?
Complementary methods are needed to discriminate between func-
tional low-abundance transcripts and both transcriptional noise and
process artifacts in regions of transcription detected by RNA-Seq. Such
discriminationwould aim to produce a reliable testable hypothesis sub-
ject to validation. Signal deconvolutiondealswith ill-posed problems [7]
derived from the convolution of splice variants through read mapping.
In order to balance any insufﬁcient sampling of the transcriptome (i.e.
low expressions preventing from detecting structures), the consider-
ation of how to transform low expression data to provide improved
transcript re-capture may be worthy. This step would involve change-
of-coordinate (projective) approaches or re-scaled (transformed)
models and several ﬁltering, smoothing and prediction algorithms be-
longing to the realm of non-parametric inference, i.e. data-driven rather
than based on probabilistic assumptions.
A ﬁeld of natural application would especially be dark matter [34].
This term indicates sequences of unidentiﬁed type and ill-determined
functions,which can contain both coding andncRNA as long as the func-
tions remain unclear, but also refer to the transcription from intergenic
regions of annotated genes. An open question is whether the ncRNAs
are biologically relevant or not. If suspected to be irrelevant, why their
functions appear persistent? If so, how their expression patterns can
be distinguished from the signature of transcriptional noise? One of
the hypotheses underlying such novel transcripts is that they are a by-
product, rather than an independent functional unit. Dark matter
could arise from extended or complex transcription of known genes,
may promote the transcription of neighboring protein-coding genes,
and arise from regions predicted to contain open chromatin, suggesting
possible regulatory roles for ncRNAs regulating epigenetic memory
through modiﬁcations to DNA and chromatin structure [35–37].
Read mapping of RNA-Seq to intergenic regions displays correlation
with proximal genes or annotationwith novel exons. Intergenic regions
present usually a mix of potentially coding (extended transcripts) and
separated non-coding transcripts. Complications arise because the true
number and level of different transcript isoforms are not usually
known, and transcription activity varies across the genome. Transcrip-
tion is considered an efﬁcient regulatory process in cells, organisms
and tissueswhich controls the complex formof gene expression. Speciﬁc
events such as pausing (and backtracking) affect transcription, and the
heterogeneity in transcription rate makes it not a continuous process,
but a process subject to interruptionswith negative effects on transcrip-
tion. In this mini-review, the goal is to assess the power of data-driven
inference in uncovering transcriptome features. From a computational
side, read mapping uncertainty involves the problem that reads do not
span entire transcripts, thus the transcripts fromwhich they are derived
are not always uniquely determined and many reads align to multiple
transcripts. Consequently, an identiﬁability problem occurs, which in
the context of RNA-Seq data translates into different parameters (relative
transcript abundances) generating different probability distributions on
the read counts, and in turn affects the transcript assembly task whose
relative abundance estimation is limited by the transcriptome incom-
pleteness. If each target genetic feature is considered a particular en-
tity for which the population size has to be estimated, the problem of
sequencing sampling can be seen as random sampling of each entityaimed to estimate the relative abundances in the corresponding pop-
ulation. SRS statistical techniques can offer a solution to validate the
detected structures against null models, and thus test ﬁrst their sta-
tistical, and then their biological signiﬁcance. The paradigm shift
thus redeﬁnes the sampling process of RNA-Seq, from endogenous
sampling (biological and technological types) to post-processing
re-sampling (statistical type).
6. Alternative splicing & isoform modeling
AS is a process bywhich a single DNA sequence can be transcribed in
multiple mRNAs. When this process occurs in protein-coding genes it
enhances the transcriptome (and in turn the proteome). Despite a ma-
jority of multi-exon genes undergoing AS in a tissue-speciﬁc way, the
fraction of functional versus spurious splicing remains undetermined.
At the protein level, AS isoforms may have different patterns. It is
known in part how to use RNA-Seq data to infer the existence of novel
isoforms in known transcribed regions. The accurate mapping of reads
that span splice junctions is a crucial step in RNA-Seq data analysis.
Reads are usually short and can map to multiple isoforms at the same
time. Thus, genes with multiple isoforms complicate the task of deter-
mining which (known or unknown) isoform produced each read (iso-
forms are sampled non-uniformly, i.e. with probability proportional to
their length). Consequently, for some genes the isoform expressions
are non-identiﬁable and cannot therefore be estimated separately. The
following are challenging problems:
1. Most generated splice variants have to be evaluated, starting from one
aspect — are they constitutive or not?
2. For the genes expressing multiple splice variants there is uncertainty
about the predominant one in any tissue or cell type;
3. The dynamic nature of AS implies that ﬂuctuations characterize isoforms
at different timescales, affecting model reduction and selection.
It is expected for only a small number of factors to be involved in any
AS event, thus implying an overall control exerted by relatively few reg-
ulators. In turn this would lead to a simpliﬁcation of the problem of
identifying isoform diversity and providing recovery from various ex-
pression levels. However, there's no universally recognized best compu-
tational method for inferring isoforms from short reads.
7. What models to use?
Part of the complexity derives from the fact that different isoforms
can generate common reads that collapse over the multiple transcripts
producing them. Approaches centered on inverse problems to estimate
isoforms are a potential direction to follow. Inverse problems call for
models contemplating the presence of both observable and latent vari-
ables; these latter unknown components must be identiﬁed and esti-
mated, thus permitting a successful recovery. Some of the key
properties required are related to data (sparsity),models (compressibil-
ity) and methods (efﬁciency). As previously stated, CS allows to efﬁ-
ciently reconstruct an unknown vector of N entries from only k b N
measurements. Therefore, it leverages on the concept of sparsity. Trans-
lated into the isoform context, CS would consider a vector X of isoforms
associated with a gene of unknown length N. The Y measurements of
lengthM (M b N), are associated with entries whose values depend on
observed isoform features, such as measured expression.M is the sens-
ing isoform matrix carrying information through measurable features.
The number of reads can be proxy of some entities at a given locus,
for instance the number of isoforms of a certain gene. Such number
would provide an estimate of the number of isoforms, i.e. the length N
of the vector. Outside a coding region, and proportionally to the overall
abundance, we might observe the presence of a number of reads that
might be targeting the same gene, in case the latter lacks sufﬁcient ap-
proximation power (coverage), or otherwise indicates ncRNA transcrip-
tional activity. The goal should be to infer isoforms when they are
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mechanism, without penalizing low-expressed but functionally rele-
vant transcripts. Then, it would be worth considering the attempt of
heading a minimal isoform set that is able to explain the read data by
multiple features, while using dimensionality reduction algorithms to
make it a feasible goal.
8. Expression proﬁling (multidimensionality and
dynamic enhancement)
Mixtures of hidden isoforms form a dynamic layer of the tran-
scriptome, which combined with changes in expressions, can inﬂuence
functional analysis. Gene expression and regulation are intrinsically sto-
chastic and noisy processes responsible for the stochastic variation in
the transcriptome. Processing RNA-Seq data in dependence of condi-
tions referred to different time points, requires consideration of tempo-
ral dependence to ensure that the most likely estimable parameters
maximize the probability of observing the experimental data (e.g. the
maximum likelihood estimates). As more variables and parameters in-
crease the complexity of themodel, penalties should be used to discount
the complexity by inducing regularization.
9. How to deal with dynamics?
Biological systems have been investigated also with respect to the
reconstruction of the phase space of the generating dynamical process
[38,39]. A dynamical system is assumed to perform a trajectory in a
state-space spanned by the gene expression levels (ormRNA concentra-
tions) representing the state space variables. This way, a time-course
proﬁle could be considered dynamically enhanced when the time-
ordered levels of gene expression detected at each phase are
concatenated to form a temporal record of measurable quantities. Sev-
eral projective and regularized methods could be applied to separate
signal from noise, to identify components, and to estimate the correla-
tion. Phenotypes match some regions of the gene expression signatures
in the state-space; the signature is a speciﬁc feature, and the multidi-
mensional landscape includes each phenotype representing a point or
an example. When projective decomposition techniques are applied,
the identiﬁed components should reﬂect dysregulated pathways, due
to the perturbations, and persistent versus transient proﬁles from the
gene sets enriching for the pathways. When n states are observed,
with n big, an ensemble is obtained thus allowing for consideration of
steady dynamics. Before steady-state dynamics, transient dynamics
can be observed and such non-equilibrium conditions require statistical
methods to infer the important mechanisms behind such dynamics.
10. Differential network analysis
Differential network biology [40] proposes novel approaches based
on the comparison between topological conﬁgurations and modular
structures in health versus disease states, or given two different disease
states or perturbations, often supported by expression, genetic, and
clinical information. In particular, the variation may reﬂect the distinc-
tiveness inmolecular signatures of gene expression and protein transla-
tion arising from different combinations of genetic mutations. Once
such signatures are assigned to network nodes, topological and biolog-
ical features may elucidate interactions and causal relationships. Partic-
ularlywhenmolecular complexes or signalingpathways are considered,
the identiﬁcation of cancer-related hubs and interface proteins (in topo-
logical terms), or upstream signals and downstream targets (in path-
way localization terms), may involve differential connectivity or gene
co-expression (possibly co-regulation) patterns that lead to a sub-
network or pathway-centric marker classiﬁcation [41–43]. Targeting
altered signaling networks can suggest novel therapeutic strategies
classiﬁed within the ﬁeld of network medicine [44]. For instance,
tumor progression involves signaling network robust rewiring for thetransmission of phenotypic alterations, which implies that module-
coordination occurs as a system's level response [45].
11. What's at play?
Spatiotemporal dynamics are rarely represented within network
maps, usually replaced by averages taken over conditions or time
points, despite the importance of revealing their inherent potential to
represent aggregates of many entities in simultaneous relationships.
Once the dynamic data sources are generated, say through gene expres-
sion proﬁles, active network components may be identiﬁed by direct
extension (with genes) or simply by mapping (with proteins). Repeat-
ing in parallel this operation at each given time, say, would generate
transcript proﬁling coupled with network conﬁguration proﬁling,
where in the latter comparisons between components; i.e. active versus
unaffected ones, can be performed at each step. These components may
represent relevant summaries of biological activities, such as pathways,
obtained through the system's dissection by projective techniques
(i.e. decorrelated, independent, etc.) whose proﬁle can be monitored
step by step. In general, changes in network conﬁgurations may refer
to the structure of modularity, in terms of both module composition
and inter-module connectivity patterns.
Different types of networks are known, for instance: i) Gene regula-
tory networks; ii) Protein interactome networks (PIN, see [46] for
seminal deﬁnitions); iii) MicroRNA gene (target) networks. In particu-
lar, PIN can employ stochastic network inference approaches (see
[47–49], with regard to the resolution limit problem [50]), leading
from modularity to sub-modularity through a variety of probabilistic
methods comparatively evaluated and functionally validated at differ-
ent scales (see also [51]).
A central point is that rather than the ability of identifying modules
or clusters according tomanypossible algorithms, it is the accuracywith
which modules and functional entities match that really matters, espe-
cially whenmultiple network layers (biological processes, protein com-
plexes, and pathways) are considered [52]. We generally add further
dimensions to gain information; for instance, investigation with refer-
ence to cross-correlation patterns of microRNA-target co-expressed
proﬁles.
In the context of the RNA-Seq features, the identiﬁcation (and diver-
sity) of alternative-spliced isoforms [53] is very important. In particular,
when considering the translation of AS-generated transcripts into pro-
teins, it is natural to consider the RNA-Seq expression proﬁles as possible
drivers of an in-depth exploration of PIN regions and detection of active
sub-networks [54]. At both whole- and local sub-interactome scales
such modules will be characterized by high connectivity densities and
signiﬁcant differential co-expression. This in turn will allow inference
on condition/time-dependent regulators integrated within the network
to assess the potential of driving modularity. From the design of differ-
ential regulation maps, the focus should go to pathways and modules
aimed at detecting speciﬁc pattern propagation dynamics of the related
signals. By looking at the conﬁgurations of activemodules/motifs, it will
be possible to observe changes in the structure of either separated or
overlapping modules, pathway cross-links with respect to both bottle-
necks and bridges (depending on the relevance of the information
ﬂow crossing the node, or also on the speciﬁc role played in each mod-
ule), andwhether such changes can be characterized in transient or per-
manent terms (for instance, the constitutive components form the core
of complexes that change dynamically due tomodule addition/subtrac-
tion). Finally, concerning a combined use of drugs derived by identifying
critical sub-networks rather than individual genes, the candidate set of
target proteins will be localized in speciﬁc network regions and moni-
tored relatively to distinctiveness and speciﬁcity of topological
signature.
Such detailed information from the modules, also integrated with
additional records (clinical, therapeutic, etc.), should deliver a few ad-
vantages: a) Expanding the potential number of candidate targets
129E. Capobianco / Computational and Structural Biotechnology Journal 11 (2014) 123–130from inferring both network-dependencies and module-speciﬁc inﬂu-
ences on dysregulated cellular functions; b) Increasing the probability
of selecting novel target candidates instead of highly targeted proteins
(i.e. multiple compounds targeting the same protein) or off-targets
(i.e. those not directly perturbing the proteins involved in cancer [55]);
and c) Suggesting prediction of protein connections by assigning
weights based on network robustness and stability properties measured
at local rather than global scale.
12. Integrative view
Transcriptomics can provide a rich ground for causal inference,
i.e. helping to elucidate the possible causes behind the changes of
the organization assessed at network topology level. The correlation
between transcriptional and protein network proﬁles is not
completely predictable, as control/regulationmechanisms can be ac-
tive at both levels. Several different protein variants may be encoded
by genes, likewise post-translational modiﬁcations may occur in key
proteins. However, scrutinizing the transcriptome proﬁles over time
and coupling themwith network conﬁguration proﬁles to ﬁnd corre-
lated patterns, has a great potential, together with limitations. First,
such coupling (or uncoupling) degree could be tissue-dependent.
Then, regulatory roles of ncRNA or insight on possible gene exten-
sions could be inferred frommonitoring the changes in network con-
ﬁgurations at both module and pathway scales.
Many transcriptionally active regions are currently not annotated [53],
and novel discoveries are regularly coming out, as it was shown in [56] by
the choice of the brain tissue as a source of evidence for pseudogenes (an-
notated or not). Notably, this study has revealed that under both normal
(data source: Illumina Human BodyMap 2.0 Project on transcription pro-
ﬁling computed on the basis of high-throughput sequencing of both indi-
vidual and a mixture of sixteen normal human tissue RNA, http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30611) and disease (data
source: TCGA — The Cancer Genome Atlas — http://cancergenome.nih.
gov/cancersselected/lowergradeglioma, i.e. data from samples of lower
grade glioma) conditions the obtained quantiﬁcationswere in substantial
amount.
By examining the distribution of intergenic reads (readsmapped be-
tween currently annotated gene, i.e., readsmapping outside the furthest
5′ and 3′ exons for every gene) across the genome, any denselymapped
region could become a good target. However, reads mapping to
intergenic locations tend to fall near annotated genes, suggesting that
many annotations may require revision. This sort of prediction power
underlying the transcriptome could be monitored through the dynam-
ics transferred to networks and reﬂected into new associations (aggre-
gation of separate interactions) and dissociations (break down) of
modular structures. Intuitively, the natural quantity to monitor is the
degree of participation in network activities, assuming that each mod-
ule has a functional (i.e. biologically relevant) value. Thus, one goal is
to check how differential conditions affect the participation to modules,
and both measures of centrality and vertex–vertex distances offer in-
sight on dynamics inducing a re-positioning of vertexes in the network.
13. Concluding remarks
Transcriptome complexities require, before proceeding to their in-
depth characterization in any particular application, the following treat-
ments: 1) The ability to perform deconvolution of transcript data struc-
tures by ad hoc computational statistics and machine learning
approaches tomake effective the targeting of structural entities, ncRNAs
and gene isoforms (AS transcripts); 2) The examination of AS dynamics
and development of isoform models with multiple features; and 3) A
dynamic enhancement of the expression proﬁles of various types of
transcript entities by considering time and space at both experimental
measurement and computational analysis levels.Challenging data structures call for innovative inference methods to
deal with the complexities characterizing human transcriptomes under
different conditions. The following objectives are set to achieve high-
impact results:
i) Identify classes of problems with complexities for which innova-
tive methods are needed;
ii) Design novel data-intensive inference approaches beyondagnos-
tic learning and heuristic algorithms according to a well-deﬁned
model framework; and
iii) Provide proof-of-principle studies to establish legitimacy for the
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